Search results for: orphan drugs

Indication based pricing

In the current climate of tighter budgetary controls and greater price scrutiny, a uniform pricing s...

Read more
Cost effective HTA evaluations

The methodology to be used within the cost-effectiveness HTA evaluations is likely to be based on a ...

Read more
Multi-country drug procurement

Some governments have looked to collective procurement with other countries, to in theory result in ...

Read more
The rise of speciality products

It is the responsibility of CCGs to manage their local drug budgets

Read more
PMA Presentation July 2015

In this issue is an overview of the future changes to the UK Cancer Drug Fund as well as approaches ...

Read more
The rise of speciality products

Pharmaceutical companies are able to charge significantly higher prices as these products are addres...

Read more
Includes Biosimilar discounts, recent developments

This issue includes topics such as the recent AIFA approval of Avastin for off label use in Wet-AMD ...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.